Tara Shertel

COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era

A. Anamisis, D. Salerno, Marcus R. Pereira, 2022, American Journal of Transplantation.

Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients

D. Salerno, D. Jennings, J. Choe, 2022, Transplantation.

Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID‐19 in solid organ transplant recipients

D. Salerno, Marcus R. Pereira, D. Jennings, 2022, American Journal of Transplantation.

Nirmatrelvir/ritonavir use: Managing clinically significant drug‐drug interactions with transplant immunosuppressants

L. Ratner, D. Salerno, Marcus R. Pereira, 2022, American Journal of Transplantation.

Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization

D. Serur, Vikram Wadhera, Y. Yushkov, 2022, Nephrology.

Managing the significant drug‐drug interaction between tacrolimus and letermovir in solid organ transplant recipients

A. Anamisis, D. Salerno, J. Scheffert, 2021, Clinical transplantation.

Nitazoxanide treatment for norovirus infection in solid organ transplant recipients

A. Anamisis, D. Salerno, D. Jennings, 2022, Clinical Transplantation.